Literature DB >> 31147158

Naturally occurring and synthetic constitutive-active cytokine receptors in disease and therapy.

Doreen M Floss1, Jürgen Scheller2.   

Abstract

Cytokines control immune related events and are critically involved in a plethora of patho-physiological processes including autoimmunity and cancer development. Mutations which cause ligand-independent, constitutive activation of cytokine receptors are quite frequently found in diseases. Many constitutive-active cytokine receptor variants have been directly connected to disease development and mechanistically analyzed. Nature's solutions to generate constitutive cytokine receptors has been recently adopted by synthetic cytokine receptor biology, with the goal to optimize immune therapeutics. Here, CAR T cell immmunotherapy represents the first example to combine synthetic biology with genetic engineering during therapy. Hence, constitutive-active cytokine receptors are therapeutic targets, but also emerging tools to improve or modulate immunotherapeutic strategies. This review gives a comprehensive insight into the field of naturally occurring and synthetic constitutive-active cytokine receptors.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Constitutive-active receptors; Cytokine receptors; Gain-of-function receptors

Mesh:

Substances:

Year:  2019        PMID: 31147158     DOI: 10.1016/j.cytogfr.2019.05.007

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  2 in total

1.  A Molecular Communications System for the Detection of Inflammatory Levels Related to COVID-19 Disease.

Authors:  Luca Felicetti; Mauro Femminella; Gianluca Reali
Journal:  IEEE Trans Mol Biol Multiscale Commun       Date:  2021-04-08

Review 2.  IL-12 and IL-23-Close Relatives with Structural Homologies but Distinct Immunological Functions.

Authors:  Doreen M Floss; Jens M Moll; Jürgen Scheller
Journal:  Cells       Date:  2020-09-28       Impact factor: 6.600

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.